Followers | 2180 |
Posts | 21967 |
Boards Moderated | 14 |
Alias Born | 01/07/2011 |
Thursday, February 29, 2024 3:32:21 PM
Recent KZR News
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 10/29/2024 09:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2024 08:06:38 PM
- Kezar Life Sciences Announces 1-for-10 Reverse Stock Split • Business Wire • 10/28/2024 12:30:00 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 10/17/2024 01:22:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 12:47:59 PM
- Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan • Business Wire • 10/17/2024 12:35:00 PM
- Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update • Business Wire • 10/17/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 12:42:12 PM
- Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal • Business Wire • 10/10/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 09:05:27 PM
- Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis • Business Wire • 10/04/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 12:36:09 PM
- Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients • Business Wire • 09/30/2024 12:30:00 PM
- Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 09/04/2024 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:05:42 PM
- Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update • Business Wire • 08/13/2024 08:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 09:41:02 PM
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 07/10/2024 08:01:00 PM
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 06/07/2024 09:59:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:30:33 PM
- Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference • Business Wire • 05/29/2024 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:04:53 PM
- Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update • Business Wire • 05/09/2024 08:01:00 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM